GSK
701 hedge funds and large institutions have $13.1B invested in GSK in 2014 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 337 increasing their positions, 217 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less capital invested
Capital invested by funds: $15.2B → $13.1B (-$2.11B)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
31% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 58
Holders
701
Holding in Top 10
7
Calls
$210M
Puts
$145M
Top Buyers
| 1 | +$269M | |
| 2 | +$160M | |
| 3 | +$146M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$56.4M |
| 5 |
Morgan Stanley
New York
|
+$55.4M |
Top Sellers
| 1 | -$995M | |
| 2 | -$315M | |
| 3 | -$101M | |
| 4 |
Renaissance Technologies
New York
|
-$93.9M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$84.5M |